These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4114781)

  • 1. Rh blood group of grandmother and incidence of erythroblastosis.
    de Almeida JM; Rosado L
    Arch Dis Child; 1972 Aug; 47(254):609-12. PubMed ID: 4114781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Rh haemolytic disease.
    Clarke CA
    Nurs Mirror Midwives J; 1974 Oct; 139(17):57-9. PubMed ID: 4139694
    [No Abstract]   [Full Text] [Related]  

  • 3. PREVENTION OF RH-HAEMOLYTIC DISEASE: A THIRD REPORT.
    WOODROW JC; CLARKE CA; DONOHOE WT; FINN R; MCCONNELL RB; SHEPPARD PM; LEHANE D; RUSSELL SH; KULKE W; DURKIN CM
    Br Med J; 1965 Jan; 1(5430):279-83. PubMed ID: 14229706
    [No Abstract]   [Full Text] [Related]  

  • 4. Risky grandmothers in Rh disease.
    Br Med J; 1967 Aug; 3(5561):322-3. PubMed ID: 4961640
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of anti Rh immunization].
    Pinon F
    Sem Hop; 1969 Sep; 45(37):2328-33. PubMed ID: 4187740
    [No Abstract]   [Full Text] [Related]  

  • 6. [Practical questions in the immunological prevention of Rh sensitization].
    Althoff W; Schellong G; Stahl M
    Munch Med Wochenschr; 1969 Jun; 111(25):1386-95. PubMed ID: 4185511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood group incompatibility. Introduction and serologic-genetic report].
    Speiser P
    Wien Med Wochenschr; 1970 Mar; 120(13):215-7. PubMed ID: 4105436
    [No Abstract]   [Full Text] [Related]  

  • 8. [Theoretic bases of gamma-globulin prophylaxis].
    Speiser P
    Wien Klin Wochenschr; 1970 Jul; 82(27):501-6. PubMed ID: 4104687
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of hemolytic disease of the newborn using anti-rhesus (D) gamma globulin].
    Borst-Eilers E
    Maandschr Kindergeneeskd; 1969 Dec; 37(7):243-51. PubMed ID: 4188422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of RH immunization in Finland. Result of a 2-year nationwide anti-D program in Finland].
    Eklund J; Nevanlinna HR
    Nord Med; 1971 May; 85(19):592-6. PubMed ID: 4103019
    [No Abstract]   [Full Text] [Related]  

  • 11. [Information on Rh-D factor of women who have given birth in our obstetrical department].
    Kogoj-Bakić V; Vujaklija-Stipanović IK
    Bilt Hematol Transfuz; 1975; 3(3):61-4. PubMed ID: 57775
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our experiences in the prevention of Rh sensitization].
    Mikulandra F; Kapitanović IM
    Bilt Hematol Transfuz; 1975; 3(3):65-8. PubMed ID: 57776
    [No Abstract]   [Full Text] [Related]  

  • 13. [Unusual aspects of neonatal hemolytic disease].
    Lange MM; Lumare A; Baratono S
    Minerva Pediatr; 1967 Aug; 19(31):1466-7. PubMed ID: 4975678
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the anti-D-globulin-prevention of Rh sensitization].
    Haering M; Resch H
    Arch Gynakol; 1967; 204(2):232-3. PubMed ID: 4171916
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies of Rh isoimmunization.
    Dibbern HH; Monroe CH; Jennings ER
    Obstet Gynecol; 1968 Dec; 32(6):805-12. PubMed ID: 4193259
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of maternal immunization to fetal antigen D].
    Spensieri S; Storace A; Perasso F; Carnevale-Arella E; Bastiani G; De Geronimi GC
    Minerva Ginecol; 1971 Mar; 23(5):234-50. PubMed ID: 4103431
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylaxis of Rh isoimmunization].
    Policlinico Prat; 1968 Feb; 75(6):188-90. PubMed ID: 4191604
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore.
    Br Med J; 1966 Oct; 2(5519):907-14. PubMed ID: 4162098
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N; Lupaşcu G; Trifan E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemolytic Rh disease in Vizcay (current preventive possibilities)].
    Goti JL
    Rev Clin Esp; 1968 Apr; 109(1):37-46. PubMed ID: 4188597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.